Chihiro Sato

Affiliations: 
Washington University School of Medicine, St. Louis, MO, United States 
Area:
Neuroscience
Google:
"Chihiro Sato"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Capano LS, Sato C, Ficulle E, et al. (2022) Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons. Cell Stem Cell. 29: 918-932.e8
Lim YY, Maruff P, Barthélemy NR, et al. (2022) Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease. Jama Neurology
Ezerskiy LA, Schoch KM, Sato C, et al. (2021) Astrocytic 4R tau expression drives astrocyte reactivity and dysfunction. Jci Insight
Sato C, Mallipeddi N, Ghoshal N, et al. (2021) MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology. Annals of Clinical and Translational Neurology
Horie K, Barthélemy NR, Sato C, et al. (2021) Corrigendum to: CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease. Brain : a Journal of Neurology
Horie K, Barthélemy NR, Sato C, et al. (2020) CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease. Brain : a Journal of Neurology
Horie K, Barthélemy NR, Mallipeddi N, et al. (2020) Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain. Acta Neuropathologica Communications. 8: 149
Barthélemy NR, Horie K, Sato C, et al. (2020) Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease. The Journal of Experimental Medicine. 217
Xu Y, Du S, Marsh JA, et al. (2020) TFEB regulates lysosomal exocytosis of tau and its loss of function exacerbates tau pathology and spreading. Molecular Psychiatry
Barthélemy NR, Bateman RJ, Hirtz C, et al. (2020) Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification. Alzheimer's Research & Therapy. 12: 26
See more...